Nectar Lifesciences Ltd

📋 Nectar Lifesciences FY 2026 Compliance Report: Key Insights

- Submitted Annual Secretarial Compliance Report for the year ended March 31, 2026

- Two instances of non-compliance identified: delayed financial results submission (fine of ₹212,400 including GST) and failure to provide advance board meeting notice (fine of ₹11,800 including GST)

- Fines were paid and corrective actions taken, including explanations for delays (e.g., Chairman & Managing Director's illness)

- Compliant with all other SEBI regulations, corporate governance practices, and disclosure requirements

- No material subsidiaries or auditor resignations during the period